irradiated red blood cells
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2018 (NCT03426553)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- ErythrocyteSupplementation
Erythrocyte supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03426553 | Phase 3 | Jan 15, 2018 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Government | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1